Mitchell H. Finer Insider Trading
Get free email notifications about insider trading for Mitchell H. Finer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mitchell H. Finer. Mitchell H. Finer is a Chief Scientific Officer in bluebird bio, Inc. ($BLUE) and a Director in Adverum Biotechnologies, Inc. ($AAVL) and a Director in Oncorus, Inc. ($ONCR).
Address: C/O BLUEBIRD BIO, INC. 840 MEMORIAL DRIVE, 4TH FLOOR CAMBRIDGE 02139 MA
Companies in which Mitchell H. Finer is an Insider
Adverum Biotechnologies, Inc.
Trading Symbol: ADVMIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mitchell H. Finer: Director
Holdings: 603,069 shares
Latest Transaction: Aug 02 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
bluebird bio, Inc.
Trading Symbol: BLUEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mitchell H. Finer: Chief Scientific Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 03 2015
$BLUE Market Capitalization: $2.75B
$BLUE Previous Close: $73.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Oncorus, Inc.
Trading Symbol: ONCRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mitchell H. Finer: Director
Holdings: 0 shares
Latest Transaction: Jun 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mitchell H. Finer
Sentiment: All, ADVM, BLUE, ONCR
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | ONCR | Oncorus, Inc. | Finer Mitchell H. | Director | Option Exercise | A | 16.55 | 12,500 | 206,875 | 12,500 | |
Oct 08 2020 | ONCR | Oncorus, Inc. | Finer Mitchell H. | Director | Option Exercise | A | 1.81 | 42,970 | 77,776 | 42,970 | |
Aug 02 2019 | ADVM | Adverum Biotechnol ... | Finer Mitchell H. | Director | Option Exercise | A | 13.41 | 45,000 | 603,450 | 45,000 | |
Jun 15 2018 | ADVM | Adverum Biotechnol ... | Finer Mitchell H. | Director | Option Exercise | A | 6.25 | 35,000 | 218,750 | 35,000 | |
Jun 14 2017 | ADVM | Adverum Biotechnol ... | Finer Mitchell H. | Director | Option Exercise | A | 2.75 | 33,602 | 92,406 | 33,602 | |
Jun 14 2017 | ADVM | Adverum Biotechnol ... | Finer Mitchell H. | Director | Grant | A | 0.00 | 22,727 | 0 | 603,069 | 580.3 K to 603.1 K (+3.92 %) |
Jul 01 2016 | AAVL | Adverum Biotechnol ... | Finer Mitchell H. | Director | Option Exercise | A | 4.14 | 44,248 | 183,187 | 44,248 |